What distinguishes the Major Histocompatibility Complex (MHC) from the Human Leukocyte Antigen (HLA)?

Disable ads (and more) with a premium pass for a one time $4.99 payment

Prepare for the ASU HCR240 Human Pathophysiology exam. Study with interactive quizzes and multiple choice questions, each with hints and detailed explanations. Boost your pathophysiology knowledge for success on test day!

The correct choice highlights that Major Histocompatibility Complex (MHC) and Human Leukocyte Antigen (HLA) refer to the same group of proteins, specifically in the context of humans. MHC is a broader term that describes a large set of genes responsible for immune system regulation, including the presentation of peptide antigens to T cells. HLA is used to refer specifically to MHC molecules found in humans. Essentially, HLA is the nomenclature used for the MHC proteins that are expressed in human cells, making them critical for immune response and tissue compatibility.

Understanding this relationship is vital, as it illustrates how MHC molecules play a key role in the adaptive immune system by helping the body identify self versus non-self, which is crucial for the functioning of immune responses and transplantation compatibility. The distinction between these terms often arises in discussions about immunology, organ transplantation, and autoimmune diseases, underscoring the importance of understanding both the general concept of MHC and its specific naming in the context of human immunology (HLA).

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy